(Q47851906)

6 February 2018

title

Prognostic significance of sphingosine kinase 2 expression in non-small cell lung cancer (English)

1 reference

6 February 2018

author name string

Qiushi Wang

1

1 reference

6 February 2018

Jingyuan Li

2

1 reference

6 February 2018

Guanghua Li

3

1 reference

6 February 2018

Yinghong Li

4

1 reference

6 February 2018

Chunlin Xu

5

1 reference

6 February 2018

Ming Li

6

1 reference

6 February 2018

Guangquan Xu

7

1 reference

6 February 2018

Songbin Fu

8

1 reference

6 February 2018

publication date

7 August 2013

1 reference

6 February 2018

published in

Tumor Biology

1 reference

6 February 2018

volume

35

1 reference

6 February 2018

issue

1

1 reference

6 February 2018

page(s)

363-368

1 reference

6 February 2018

https://scigraph.springernature.com/pub.10.1007/s13277-013-1051-1

exact match

0 references

cites work

The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Biologically active sphingolipids in cancer pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Targeting SphK1 as a new strategy against cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinase type 2 is a putative BH3-only protein that induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinase-1 expression correlates with poor survival of patients with glioblastoma multiforme: roles of sphingosine kinase isoforms in growth of glioblastoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Role of sphingosine kinase 2 in cell migration toward epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Differences in practice patterns and costs between small cell and non-small cell lung cancer patients in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingoid base 1-phosphate phosphatase: a key regulator of sphingolipid metabolism and stress response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinase expression increases intracellular sphingosine-1-phosphate and promotes cell growth and survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Role for sphingosine kinase 1 in colon carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Clinical significance of sphingosine kinase-1 expression in human astrocytomas progression and overall patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinase 1 in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Enhancement of radiosensitivity by combined ceramide and dimethylsphingosine treatment in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Microarray analysis of altered sphingolipid metabolism reveals prognostic significance of sphingosine kinase 1 in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

The expression of sphingosine kinase-1 in head and neck carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Panax ginseng polysaccharide suppresses metastasis via modulating Twist expression in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Purification, characterization and anticancer activity of a polysaccharide from Panax ginseng

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

A polysaccharide from Armillaria mellea exhibits strong in vitro anticancer activity via apoptosis-involved mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

The role of nuclear medicine in modern therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

Ablation of sphingosine kinase-2 inhibits tumor cell proliferation and migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-013-1051-1

High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23918304

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S13277-013-1051-1

1 reference

6 February 2018

1 reference

6 February 2018